๐๐ต๐ถ๐ป๐ฎ ๐๐ฝ๐ฝ๐ฟ๐ผ๐๐ฒ๐ ๐ช๐ผ๐ฟ๐น๐ฑ'๐ ๐๐ถ๐ฟ๐๐ ๐๐ผ๐บ๐บ๐ฒ๐ฟ๐ฐ๐ถ๐ฎ๐น ๐๐ฟ๐ฎ๐ถ๐ป ๐๐ต๐ถ๐ฝ
China approved the NEO brain chip for commercial use after successful clinical trials. The device comes from researchers at Tsinghua University and Neuracle Technology.
Key facts about the NEO implant:
- The device is a coin-sized implant.
- It sits between the skull and the brain.
- Eight sensors rest against the dura mater membrane.
- This design is less invasive than implants that penetrate the cerebral cortex.
- The chip converts brain signals into digital commands for computers or prosthetics.
- Thirty-six patients tested the device with positive results.
Primary uses and goals:
- Help patients with spinal cord injuries regain nervous system control.
- Assist people with paralysis.
- Provide future solutions for Parkinson's disease, epilepsy, stroke, and depression.
- Move into mass production for China's state-run healthcare system.
Comparison to Neuralink:
- Elon Musk's Neuralink is still conducting human trials in the United States.
- Neuralink has not received broad regulatory approval for commercial use.
- Neuralink's N1 device requires electrodes to penetrate the brain's cortex.
- Neuralink is currently testing the device on nine patients.
Risks and security concerns:
- Experts warn of potential hacks to access neural data like thoughts or memories.
- Cyberattacks could impair cognitive functions or concentration.
- Hackers might manipulate motor signals to affect physical movement.
Source: The Times of India